| Literature DB >> 28433483 |
Uranchimeg Tsegmed1, Tomoki Kimura2, Takeo Nakashima3, Yuko Nakamura4, Toru Higaki4, Nobuki Imano1, Yoshiko Doi1, Masahiro Kenjo1, Shuichi Ozawa1, Yuji Murakami1, Kazuo Awai4, Yasushi Nagata1.
Abstract
The aim of the current planning study is to evaluate the ability of gadoxetate disodium-enhanced magnetic resonance imaging (EOB-MRI)-guided stereotactic body radiation therapy (SBRT) planning by using intensity-modulated radiation therapy (IMRT) techniques in sparing the functional liver tissues during SBRT for hepatocellular carcinoma. In this study, 20 patients with hepatocellular carcinoma were enrolled. Functional liver tissues were defined according to quantitative liver-spleen contrast ratios ≥ 1.5 on a hepatobiliary phase scan. Functional images were fused with the planning computed tomography (CT) images; the following 2 SBRT plans were designed using a "step-and-shoot" static IMRT technique for each patient: (1) an anatomical SBRT plan optimization based on the total liver; and (2) a functional SBRT plan based on the functional liver. The total prescribed dose was 48 gray (Gy) in 4 fractions. Dosimetric parameters, including dose to 95% of the planning target volume (PTV D95%), percentages of total and functional liver volumes, which received doses from 5 to 30 Gy (V5 to V30 and fV5 to fV30), and mean doses to total and functional liver (MLD and fMLD, respectively) of the 2 plans were compared. Compared with anatomical plans, functional image-guided SBRT plans reduced MLD (mean: plan A, 5.5 Gy; and plan F, 5.1 Gy; p < 0.0001) and fMLD (mean: plan A, 5.4 Gy; and plan F, 4.9 Gy; p < 0.0001), as well as V5 to V30 and fV5 to fV30. No differences were noted in PTV coverage and nonhepatic organs at risk (OARs) doses. In conclusion, EOB-MRI-guided SBRT planning using the IMRT technique may preserve functional liver tissues in patients with hepatocellular carcinoma (HCC).Entities:
Keywords: Functional image-guided radiotherapy; Gadoxetate disodium-enhanced MRI; Hepatocellular carcinoma; SBRT
Mesh:
Substances:
Year: 2017 PMID: 28433483 DOI: 10.1016/j.meddos.2017.01.005
Source DB: PubMed Journal: Med Dosim ISSN: 1873-4022 Impact factor: 1.482